Oncobiologics (OTLK)
(Delayed Data from NSDQ)
$7.90 USD
+0.37 (4.91%)
Updated May 24, 2024 03:59 PM ET
After-Market: $7.89 -0.01 (-0.13%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-1.07 | -10.62% |
Earnings Summary
For their last quarter, Oncobiologics (OTLK) reported earnings of -$1.55 per share, missing the Zacks Consensus Estimate of -$0.88 per share. This reflects a negative earnings surprise of 76.14%. Look out for OTLK's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$1.07 per share, reflecting a year-over-year increase of 33.13%.
Earnings History
Price & Consensus
Zacks News for OTLK
Outlook (OTLK) Surges 31% on Regulatory Update for AMD Study
OTLK: What are Zacks experts saying now?
Zacks Private Portfolio Services